By
Latest Stories
Don’t miss our hot and upcoming stories
Is Juvenescence’s Acquisition of Ro5 the Key to Unlocking AI-Driven Longevity Therapies in 2025?
Key Insights Juvenescence Acquires Ro5 to Bolster AI Capabilities in Drug DiscoveryJuvenescence Limited, a clinical-stage…
Can AI Turn Biobank Data into Precision Drug Discovery Gold? Inside the Elucidata–Sapien Biosciences Alliance
Key Highlights Transforming Biobanks into AI-Driven EnginesElucidata, a U.S.-India based AI pioneer in life sciences,…
How Will Axxam and Molecular Health’s AI-Powered Alliance Accelerate Target Discovery and De-Risk Drug Development for Pharma?
Key Highlights: Strategic Collaboration Targets Early Drug Discovery BottlenecksAnnounced on June 4, 2025, Molecular Health…
Can Clairity’s FDA-Approved AI Breast Cancer Prediction Tool Transform How We Predict Breast Cancer Risk Over 5 Years?
Key Highlights: AI-Driven Risk Prediction: A Breakthrough in Preventive OncologyBoston-based Clairity received FDA de novo…